E-course: Update on the systemic treatment in invasive and metastatic bladder cancer
The management of patients with muscle-invasive bladder cancer (MIBC) is rapidly evolving, with remarkable progress in both neoadjuvant and metastatic treatment settings. Created by the European School of Urology and the EAU Guidelines Office, this e-course will offer you the opportunity to deepen your understanding of the latest systemic therapies in the perioperative and metastatic landscape.
| Organiser | European School of Urology (ESU) |
|---|---|
| CME | 1.00 |
| Duration | Approx. 60 minutes |
We will critically explore the benefits, limitations, and challenges of current approaches, while also highlighting promising ongoing clinical trials that are shaping the future of bladder cancer care.
By the end of this e-course, you will become better equipped to integrate systemic treatment options into your clinical practice, ultimately supporting improved patient outcomes in this fast-moving and dynamic field.
Speakers:
- Dr A. Van Der Heijden (NL)
- Prof. Dr. A. Lorch (CH)
- Prof. M.I. Milowsky (US)
- Prof. Dr. R. Cathomas (CH)
This e-course is brought to you in collaboration with the EAU Guidelines Office.